Vanadium play QEM up on govt backing
QEM snares Coordinated Project status for its Julia Creek vanadium and oil shale project; Leeuwin shareholders like Marda gold deal.
Stockhead
ASX climbs closer to Christmas
Investors have seemingly been taking advantage of pre-Christmas sales, with the ASX 200 closing to the upside by a very festive 1.67%.
Road to 2025: Harvest Technology
Sarah Hughan covers Harvest Technology Group which has seen an exciting 2024 with a new CEO, a pathway to profitability and new shareholders.
QEM gets key government tick
QEM’s flagship vanadium and oil shale development has been declared a Coordinated Project by the Queensland Government.
More Stories
Canary Capital thinks these gold stocks could fly
Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors.
The year crypto went mainstream
The crypto market has entered a new era of growth and mainstream adoption, with 2024 representing a significant turning point, writes James Quinn-Kumar.
Leeuwin surges on Marda gold deal
Leeuwin climbs after acquiring the Marda project from Ramelius, while Iltani pops up with high-grade drill results at Orient.
Gold bulls watching more than US rates
MineLife’s Gavin Wendt says gold is his key commodity pick for 2025, with analysts not just basing their bets on interest rates.
ASX hits three-month low
The local bourse hit a three-month low on Friday as CBA led the banks down, Mesoblast gave back some of its 50pc gain and the ASX had a CHESS outage.
Copper explorer MHM lists on the ASX
Mount Hope Mining has already identified five priority exploration prospects at its project in NSW’s Cobar region for exploration in early 2025.
Clean energy’s on track – can we speed it up?
Clean energy is moving ahead, believe experts, but with key tech still in diapers, hitting ultimate climate goals is no sure thing.
This biotech fell off its perch this week
Percheron fell ~90% in a week Morgans analyst Scott Power described as one of both good and bad news for the ASX healthcare sector.
Lumos starts CLIA waiver study in US
Lumos has begun a crucial study in the US for its FebriDx point-of-care test to aid in differentiation between bacterial and non-bacterial acute respiratory infections.
Road to 2025: OCT
Sarah Hughan explores Octava Minerals and its advancement into an antimony market showing little slow down.
Original URL: https://www.adelaidenow.com.au/business/stockhead/page/3